A detailed history of Cowen And Company, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 3,756,469 shares of PTCT stock, worth $152 Million. This represents 2.94% of its overall portfolio holdings.

Number of Shares
3,756,469
Previous 3,725,626 0.83%
Holding current value
$152 Million
Previous $108 Million 5.99%
% of portfolio
2.94%
Previous 3.64%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$24.69 - $40.12 $761,513 - $1.24 Million
30,843 Added 0.83%
3,756,469 $115 Million
Q4 2023

Feb 12, 2024

BUY
$18.07 - $29.37 $67.3 Million - $109 Million
3,725,626 New
3,725,626 $103 Million
Q2 2023

Aug 07, 2023

BUY
$40.4 - $59.1 $32.3 Million - $47.3 Million
799,511 New
799,511 $32.5 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.9B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.